Anagliptin Completed Phase 2 Trials for Type 2 Diabetes Mellitus

IndicationsStatusPurposePhase
CompletedNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT00532506Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus